Clinical Pharmacology Solutions
Become better informed about your Clinical Pharmacology Data. Ensure your PK/PD science aligns with your clinical strategy for smarter decisions, better trial designs, and stronger submissions.
Understanding Your Clinical Pharmacology Data
Success in drug development depends on more than generating data—it requires interpreting that data and applying it strategically. Clinical pharmacology integrates disciplines such as bioanalysis, formulation sciences, pharmacokinetics (PK), pharmacodynamics (PD), and pharmacology.
When these disciplines are considered together, they provide a better understanding of your drug, the impact of pharmacogenomics on exposure differences of your drug, or the relevance of food-drug or drug–drug interactions. When combined, these insights form the roadmap that drives dose selection, trial design, and regulatory alignment—ultimately strengthening that deeper understanding of your drug candidate and the probability of success for your program.
Xyzagen’s Clinical Pharmacology Solutions
At Xyzagen, we provide clinical pharmacology solutions that go beyond reporting numbers. Our team helps you interpret PK, PD, and toxicokinetic results in context, guiding smarter decisions throughout preclinical and clinical development.
Xyzagen combines scientific expertise with decades of practical experience to deliver actionable insights at every stage of drug development. Our team partners with clients to design, analyze, and interpret studies across preclinical, Phase I, and later-stage clinical trials. By integrating GLP toxicokinetics, bioanalytical support, modeling, and data-driven decision-making, we help optimize trial design, support regulatory submissions, and ensure your development program progresses efficiently and confidently.
Our Clinical Pharmacology Capabilities
Our Clinical Pharmacology Solutions span early preclinical studies through Phase III trials, including:
Phase 1 Noncompartmental PK Analysis
Performing first-in-human and early clinical PK analyses to evaluate safety, dose, and exposure relationships.
Phase 2–3 Clinical Trial PK Analysis
Supporting later-stage studies with integrated PK/PD analysis and population PK to inform dosing and efficacy decisions.
Clinical Pharmacology Design & Analysis
Leveraging expertise to optimize study design, endpoint selection, and statistical analysis for regulatory submissions.
PK Kit Services
Turnkey Phase 2 and 3 PK sub-study solutions with consistent, high-quality sample collection and analysis across sites.
Why Choose Xyzagen as Your Clinical Pharmacology Partner?
Large CROs often provide data without context. Xyzagen delivers something different: senior scientists who act as both pharmacologists and strategists. Our boutique approach ensures your program is guided by decades of hands-on experience, with insights that anticipate regulatory expectations and strengthen every milestone. We focus on what the body does to the drug—not just reporting results—so you can build development decisions on a solid scientific foundation.
Partner with Xyzagen
Contact us today to learn how our Clinical Pharmacology Solutions can help you optimize study design, streamline regulatory submissions, and advance your program with confidence.
